AYA.TO vs. RIGL
AYA.TO (Aya Gold & Silver Inc.) and RIGL (Rigel Pharmaceuticals, Inc.) are both stocks. AYA.TO operates in Other Precious Metals & Mining (Basic Materials), while RIGL operates in Biotechnology (Healthcare). Over the past 10 years, AYA.TO returned 46.86%/yr vs 4.17%/yr for RIGL. At a 0.06 correlation, their price movements are largely independent.
Performance
AYA.TO vs. RIGL - Performance Comparison
Loading charts...
Different Trading Currencies
AYA.TO is traded in CAD, while RIGL is traded in USD. To make them comparable, the RIGL values have been converted to CAD using the latest available exchange rates.
Returns By Period
In the year-to-date period, AYA.TO achieves a 33.04% return, which is significantly higher than RIGL's -21.66% return. Over the past 10 years, AYA.TO has outperformed RIGL with an annualized return of 46.86%, while RIGL has yielded a comparatively lower 4.17% annualized return.
AYA.TO
- 1D
- 7.49%
- 1M
- -10.88%
- YTD
- 33.04%
- 6M
- 24.61%
- 1Y
- 98.56%
- 3Y*
- 42.66%
- 5Y*
- 25.69%
- 10Y*
- 46.86%
RIGL
- 1D
- 2.70%
- 1M
- 4.40%
- YTD
- -21.66%
- 6M
- -18.21%
- 1Y
- 57.85%
- 3Y*
- 29.05%
- 5Y*
- -1.12%
- 10Y*
- 4.17%
AYA.TO vs. RIGL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AYA.TO Aya Gold & Silver Inc. | 33.04% | 82.87% | 10.61% | 7.65% | -5.55% | 148.05% | 97.44% | 2.09% | 16.46% | 192.86% |
RIGL Rigel Pharmaceuticals, Inc. | -21.66% | 143.01% | 25.82% | -5.63% | -39.81% | -24.32% | 59.67% | -10.79% | -35.74% | 51.99% |
Correlation
The correlation between AYA.TO and RIGL is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.10 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.12 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.09 |
Correlation (All Time) Calculated using the full available price history since Jul 24, 2008 | 0.06 |
Fundamentals
AYA.TO:
CA$3.88B
RIGL:
$646.69M
AYA.TO:
$0.60
RIGL:
$19.21
AYA.TO:
31.07
RIGL:
1.71
AYA.TO:
0.06
RIGL:
0.00
AYA.TO:
9.44
RIGL:
2.08
AYA.TO:
6.06
RIGL:
1.62
AYA.TO:
$283.62M
RIGL:
$299.77M
AYA.TO:
$155.19M
RIGL:
$279.95M
AYA.TO:
$167.72M
RIGL:
$125.80M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AYA.TO vs. RIGL — Risk / Return Rank
AYA.TO
RIGL
AYA.TO vs. RIGL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Aya Gold & Silver Inc. (AYA.TO) and Rigel Pharmaceuticals, Inc. (RIGL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AYA.TO | RIGL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.45 | ||
| Sortino ratioReturn per unit of downside risk | +0.18 | ||
| Omega ratioGain probability vs. loss probability | 1.23 | 1.21 | +0.02 |
| Calmar ratioReturn relative to maximum drawdown | 2.39 | 1.13 | +1.27 |
| Martin ratioReturn relative to average drawdown | 6.46 | 1.97 | +4.49 |
Loading charts...
Drawdowns
AYA.TO vs. RIGL - Drawdown Comparison
The maximum AYA.TO drawdown since its inception was -81.67%, smaller than the maximum RIGL drawdown of -97.52%. Use the drawdown chart below to compare losses from any high point for AYA.TO and RIGL.
Loading charts...
Drawdown Indicators
| AYA.TO | RIGL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -81.67% | -97.52% | +15.85% |
Max Drawdown (1Y)Largest decline over 1 year | -41.38% | -51.54% | +10.16% |
Max Drawdown (3Y)Largest decline over 3 years | -54.86% | -55.89% | +1.03% |
Max Drawdown (5Y)Largest decline over 5 years | -54.91% | -84.72% | +29.81% |
Max Drawdown (10Y)Largest decline over 10 years | -72.30% | -86.41% | +14.11% |
Current DrawdownCurrent decline from peak | -12.23% | -86.69% | +74.46% |
Average DrawdownAverage peak-to-trough decline | -37.46% | -76.66% | +39.20% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.31% | 29.58% | -14.27% |
Volatility
AYA.TO vs. RIGL - Volatility Comparison
Aya Gold & Silver Inc. (AYA.TO) has a higher volatility of 30.47% compared to Rigel Pharmaceuticals, Inc. (RIGL) at 11.98%. This indicates that AYA.TO's price experiences larger fluctuations and is considered to be riskier than RIGL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AYA.TO | RIGL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 30.47% | 11.98% | +18.49% |
Volatility (6M)Calculated over the trailing 6-month period | 58.25% | 36.91% | +21.34% |
Volatility (1Y)Calculated over the trailing 1-year period | 77.96% | 70.68% | +7.28% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 67.63% | 85.93% | -18.30% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 77.63% | 83.17% | -5.54% |
Dividends
AYA.TO vs. RIGL - Dividend Comparison
Neither AYA.TO nor RIGL has paid dividends to shareholders.
Financials
AYA.TO vs. RIGL - Financials Comparison
This section allows you to compare key financial metrics between Aya Gold & Silver Inc. and Rigel Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AYA.TO vs. RIGL - Profitability Comparison
AYA.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aya Gold & Silver Inc. reported a gross profit of 82.27M and revenue of 115.35M. Therefore, the gross margin over that period was 71.3%.
RIGL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a gross profit of 54.21M and revenue of 58.82M. Therefore, the gross margin over that period was 92.2%.
AYA.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aya Gold & Silver Inc. reported an operating income of 76.31M and revenue of 115.35M, resulting in an operating margin of 66.2%.
RIGL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported an operating income of 11.89M and revenue of 58.82M, resulting in an operating margin of 20.2%.
AYA.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aya Gold & Silver Inc. reported a net income of 47.54M and revenue of 115.35M, resulting in a net margin of 41.2%.
RIGL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a net income of 8.65M and revenue of 58.82M, resulting in a net margin of 14.7%.
Frequently Asked Questions
AYA.TO and RIGL have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for AYA.TO and RIGL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer